Rns out25 Mar 2019 07:14
C
25 March 2019
AIM share code: SKIN
25 March 2019
Integumen PLC
("Integumen" or "Company")
Labskin CBD tests show increase in procollagen and reduction in inflammatory skin irritation
Integumen announces the positive results of further tests in formulations, as indicated in its announcement of 20 February 2019. These formulations, all of which contain low-concentrations of hemp-derived Cannabinoid (CBD) oils, increase production of pro-collagen in as little as 24 hours, and indicate a reduction of inflammation on Labskin leading to a soothing effect on irritated and sore skin.
Pro-Collagen:
Pro-collagen has been shown to improve the youthfulness of skin appearance and is a precursor of collagen, the protein that adds strength and support to body tissue. The amount of pro-collagen production can be directly measured, as no additional collagen is added to the Labskin model.
Anti-inflammatory properties:
Inflammation, or the painful reddening and swelling of the skin, can be caused by a variety of reasons from bacterial infection to irritation from harsh skin products. Labskin is capable of releasing chemical markers that indicate inflammation damage occurring on the skin test model. The trial data shows that formulations containing hemp-derived CBD oil, in low concentrations, reduce the release of these inflammation markers indicating a soothing effect on sore skin.
Updated test results
The Company trading updates of 7 January 2019 and 20 February noted that Cellulac (9.35% owned by Integumen) had developed a low-cost hemp-derived CBD oil extraction process and was collaborating with Labskin to provide a formulation for the STOER For Men range of cosmetics.
Gerard Brandon (Chief Executive Officer) commented:
"Scientific evidence to back up anti-ageing or problematic skin treatments is far superior to anecdotal percentages of product testers. With no animal testing allowed, consumers still have a right to know what the real impact and effect of products have on their skin, before they use it.
Further tests and product approvals are still required before consideration of launching an extension to the range of STOER For Men skin care products. Labskin is now offering the same test services to clients adding CBD to their skin-care and cosmetic range of products
Sign In
Follow the stocks
